🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,756 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6566500

Compositions and methods for modifying toxic effects of proteinaceous compounds

The Board of Regents of the University of Texas System · Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6562801

PpGpp and pppGpp as immunomodulatory agents

The Board of Regents of the University of Texas System · Granted Tue May 13 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6551830

Rh blood group antigen compositions and methods of use

The Board of Regents of the University of Texas System · Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6551774

Diagnostic methods for conditions associated with elevated cellular levels of telomerase a

The Board of Regents of the University of Texas System · Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6537804

BCR-ABL directed compositions and uses for inhibiting Philadelphia chromesome stimulated c

The Board of Regents of the University of Texas System · Granted Tue Mar 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6524583

Antibody methods for selectively inhibiting VEGF

The Board of Regents of the University of Texas System · Granted Tue Feb 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6518063

Osf2/Cbfa1 nucleic acids and methods of use therefor

The Board of Regents of the University of Texas System · Granted Tue Feb 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6517828

C-CAM as an angiogenesis inhibitor

The Board of Regents of the University of Texas System · Granted Tue Feb 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6514942

Methods and compositions for stimulating T-lymphocytes

The Board of Regents of the University of Texas System · Granted Tue Feb 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6515118

DNA fragmentation factor

The Board of Regents of the University of Texas System · Granted Tue Feb 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6511847

Recombinant p53 adenovirus methods and compositions

The Board of Regents of the University of Texas System · Granted Tue Jan 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6509319

EDTA and other chelators with or without antifungal antimicrobial agents for the preventio

The Board of Regents of the University of Texas System · Granted Tue Jan 21 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6509317

Method of treating chronic cardiac disease

The Board of Regents of the University of Texas System · Granted Tue Jan 21 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6503914

Thienopyrimidine-based inhibitors of the Src family

The Board of Regents of the University of Texas System · Granted Tue Jan 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6503916

Treatment of ischemic brain injury

The Board of Regents of the University of Texas System · Granted Tue Jan 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6503915

Composition and method for treatment of cerebral ischemia

The Board of Regents of the University of Texas System · Granted Tue Jan 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6503498

Apolipoprotein A-1 adenovirus vector compositions and methods

The Board of Regents of the University of Texas System · Granted Tue Jan 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6500798

Use of colostrinin, constituent peptides thereof, and analogs thereof, as oxidative stress

The Board of Regents of the University of Texas System · Granted Tue Dec 31 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6500834

Composition and method for treatment of cerebral ischemia

The Board of Regents of the University of Texas System · Granted Tue Dec 31 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6492104

EIA test using nondenatured HIV antigen for early detection of HIV infection

The Board of Regents of the University of Texas System · Granted Tue Dec 10 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6489163

Ribozyme mediated inactivation of the androgen receptor

The Board of Regents of the University of Texas System · Granted Tue Dec 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6486166

Suppression of cyclin kinase 2 activity for prevention and treatment of DNA viral infectio

The Board of Regents of the University of Texas · Granted Tue Nov 26 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6482795

Tumor suppressor designated TS10q23.3

The Board of Regents of the University of Texas System · Granted Tue Nov 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6482803

Modification of mutated P53 gene in tumors by retroviral delivery of ribozyme A

The Board of Regents of the University of Texas System · Granted Tue Nov 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired